Clear Health Pass and CMS Coverage Group Convene Working Session on ASP and HCPCS Code Integrity for Q4347
The Tribal Consortium’s Authorized Tribal Agent, Clear Health Pass Holdings, joined a working session with CMS Drug Pricing and the Coverage and Analysis Group to address the Average Sales Price submission and HCPCS code record for Rampart™ DL Matrix (Q4347). The...Clear Health Pass Holdings Acquires Exclusive Worldwide Rights to Rampart™ DL Matrix as Authorized Tribal Agent
Clear Health Pass Holdings, LLC today completed its acquisition of exclusive worldwide commercial rights, administrative authority, and HCPCS Q-code holder responsibilities for Rampart™ DL Matrix (Q4347), the FDA-cleared advanced wound care matrix used by physicians...Clear Health Pass Presents Tribal Sovereign Framework to CMS and Novitas Solutions Policy Team
The Tribal Consortium, represented by Clear Health Pass Holdings, joined Centers for Medicare & Medicaid Services policy leadership and Novitas Solutions — the Medicare Administrative Contractor authoring the Local Coverage Determination for skin substitute...Tribal Consortium Submits Joint LCD Guidance to CMS on Skin Substitute Coverage Policy
On June 6, 2024, the Tribal Biotechnology & Health Consortium — through its founding partner, Blue Lake Rancheria Economic Development Corporation — submitted formal comments to the Centers for Medicare & Medicaid Services on the Local Coverage Determination...
